| 产品描述: | CCR4-351 is an orally active, potent and selective CCR4 antagonist. CCR4-351, featuring a novel piperidinyl-azetidine motif, has IC50s of 22 nM and 50 nM in the calcium flux and CTX assay. CCR4-351 has antitumor activity. |
| 靶点: |
CCR4 |
| 体内研究: |
CCR4-351 (化合物 38) 在 CYP450 诱导试验中没有活性。 CCR4-351抑制小鼠和人的 iTreg细胞的迁移,IC50为39 nM 和 33 nM。 |
| 参考文献: |
1. Omar Robles, et al. Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as Single Agent and in Combination with Checkpoint Inhibitors. J Med Chem. 2020 Jul 15. |
| 保存条件: |
-80°C 12个月; -20°C 6个月, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.998 ml |
9.992 ml |
19.983 ml |
| 5 mM |
0.4 ml |
1.998 ml |
3.997 ml |
| 10 mM |
0.2 ml |
0.999 ml |
1.998 ml |
| 50 mM |
0.04 ml |
0.2 ml |
0.4 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |